After 70, Your Muscles Are Dying — This One Protein Reverses It (Eggs Can't Come Close)

Key Wellness & Self-Care Strategies (Muscle Preservation After 70)

Understand the problem: age-related muscle loss is real and fast after 70

• Muscle protein breakdown outpaces repair with age.
• Sarcopenia risk increases sharply after 65 and can lead to a “disability cascade”:
  • mobility → dependency → hospitalization

Practical screening (self-check)

• Grip strength: < 27 kg (men) or < 16 kg (women)
• Walking speed: < 0.8 m/s (over ~4 meters)
• Chair stand test (no arm push-off):
  • 5 reps > 12 sec = clinically in sarcopenic range
  • 5 reps > 15 sec = higher risk of disability cascade

Core mechanism: fight “anabolic resistance”

• After 70, older muscle needs a stronger trigger to turn on muscle protein synthesis.
• The key chemical “switch” is mTORC1, activated strongly by leucine (not just “protein” broadly).
• After 70, the leucine threshold rises—you need a bigger leucine spike per meal.

---

Evidence-Based “4-Variable” Protocol (Main Actionable Takeaway)

Do not treat these separately—each variable supports the others.

1) Protein (whey isolate) - Dose: 35–40 g whey isolate per serving (non-negotiable) - Timing: - Take within 30 minutes of resistance exercise - On non-training days: distribute across meals (at least 2 servings/day) to avoid missing the anabolic response and hitting a “protein ceiling” per meal - Leucine targeting: choose a product with about 2.5–3 g leucine per serving - Why whey isolate (vs eggs/chicken/etc.): - Whey is fast-digesting and produces a quicker leucine rise that better matches the shorter post-exercise anabolic window in older adults. - Eggs may be “complete nutrition,” but are described as not having sufficient leucine density and absorption timing to reliably cross the higher post-70 leucine threshold.

2) Resistance Training (mechanical signal) - Minimum effective dose: 2 sessions/week - Session structure (example components): - Lower body compound: squat pattern or leg press - Upper body push: chest press or shoulder press - Upper body pull: row or lat pulldown - Effort/intensity: 70–80% of maximum effort, 3 sets per movement - If you can’t load weights: - Blood Flow Restriction (BFR): 20–30% 1RM using a cuff to restrict venous return (reported as producing a comparable muscle protein synthesis response)

3) Vitamin D3 (cellular responsiveness support) - Dose: 1,500–2,000 IU daily, taken with a meal containing fat - Testing/targets: - Ask for serum 25-hydroxy vitamin D - Target range: 75–125 nmol/L - Below 50 nmol/L = deficient; below 30 nmol/L = critically deficient - Why it matters: vitamin D receptor activity in muscle supports protein synthesis pathways and satellite cell function.

4) Creatine monohydrate (fuel for vulnerable fibers) - Dose: 3–5 g daily, no loading, no cycling - Timing: anytime; can be taken with or separate from whey - Why it matters: supports phosphocreatine availability in fast-twitch (type II) fibers, which are particularly prone to atrophy.

---

Timing & Expected Progress (What to Watch For)

• Weeks 1–2: little measurable change expected (phosphocreatine saturation + early neuromuscular adaptation)
• Weeks 4–6: strength improvements begin
• Weeks 8–12: lean mass changes become measurable
  • Re-test the chair stand and track the time difference
• Around month 6: improvements expected in functional markers like grip strength and walking speed

---

Quick “Don’t Waste Effort” Guidance

• Walking/yoga/swimming alone are described as insufficient because they may not produce the necessary mechanical loading/microdeformation to help trigger the mTOR cascade.
• Protein without resistance exercise is framed as unlikely to produce the best anabolic response.

---

Presenters or Sources (Named in the Subtitles)

• Irwin Rosenberg (1989; sarcopenia naming)
• Tufts University researchers (disability cascade mentioned)
• European Working Group on Sarcopenia in Older People (EWGSOP) (diagnostic markers; updated definition in 2019)
• Bohannon (2006; chair stand cutoff)
• David Cuthbertson (2005; older muscle needs more amino acid stimulus)
• Breen & Phillips (2011; leucine/mTOR threshold concept)
• Moore et al. (2015; protein per meal to overcome anabolic resistance; also cited 2009 whey post-exercise dose differences)
• Paddon-Jones & Rasmussen (2009; protein “ceiling”/saturation per meal)
• Koopman et al. (2009; compressed anabolic window)
• Van Vliet et al. (2017; whole egg vs egg white)
• Boirie et al. (1997; whey “fast protein” kinetics)
• Tang et al. (2009; whey vs soy vs casein in older men)
• Bauer et al. (2015; PROVIDE trial—whey + leucine + vitamin D)
• Churchward-Venn et al. (2012; adding free leucine restores MPS with subthreshold protein)
• Biolo et al. (1997; resistance + protein synergy)
• Drummond et al. (2008; post-exercise mTOR sensitivity window)
• Peterson et al. (2011; meta-analysis of resistance training trials over 60)
• Fry et al. (2010; blood flow restriction study)
• Candow et al. (2014; creatine + resistance training meta-analysis)
• Heike Bischoff-Ferrari et al. (2004; vitamin D receptor in muscle)
• Visser et al. (2003; vitamin D levels and sarcopenia risk)
• Looker et al. (2011; NHANES vitamin D status in older adults)
• Holick et al. (2011; Endocrine Society vitamin D guideline)
• Newman et al. (2006; low muscle mass predicts mortality)
• Brose et al. (2003; creatine safety evidence cited)
• Dr. Bauer and colleagues / Bauer et al. (again tied to PROVIDE trial)
• Yves Boirie (author cited within Boirie et al., 1997)